Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry

Fernando P. Filgueira, Núbia S. Lobato, Denise L. Nascimento, Graziela S. Ceravolo, Fernanda R.C. Giachini, Victor V. Lima, Ana Paula Dantas, Zuleica B. Fortes, R Clinton Webb, Rita C. Tostes, Maria Helena C. Carvalho

Research output: Contribution to journalArticle

Abstract

Conjugated equine estrogens (CEE) have been widely used by women who seek to relieve symptoms of menopause. Despite evidence describing protective effects against risk factors for cardiovascular diseases by naturally occurring estrogens, little is known about the vascular effects of equilin, one of the main components of CEE and not physiologically present in women. In this regard, the present study aims to compare the vascular effects of equilin in an experimental model of hypertension with those induced by 17β-estradiol. Resistance mesenteric arteries from female spontaneously hypertensive rats (SHR) were used for recording isometric tension in a small vessel myograph. As effectively as 17β-estradiol, equilin evoked a concentration-dependent relaxation in mesenteric arteries from female SHRs contracted with KCl, U46619, PDBu or ET-1. Equilin-induced vasodilation does not involve classical estrogen receptor activation, since the estrogen receptor antagonist (ICI 182,780) failed to inhibit relaxation in U46619-precontracted mesenteric arteries. Vasorelaxation was not affected by either endothelium removal or by inhibiting the release or action of endothelium-derived factors. Incubation with L-NAME (NOS inhibitor), ODQ (guanylyl cyclase inhibitor) or KT5823 (inhibitor of protein kinase G) did not affect equilin-induced relaxation. Similarly, indomethacin (COX inhibitor) or blockage of potassium channels with tetraethylammonium, glibenclamide, 4-aminopyridine, or ouabain did not affect equilin-induced relaxation. Inhibitors of adenylyl cyclase SQ22536 or protein kinase A (KT5720) also had no effects on equilin-induced relaxation. While 17β-estradiol inhibited calcium (Ca2+) -induced contractions in high-K+ depolarization medium in a concentration-dependent manner, equilin induced a slight rightward-shift in the contractile responses to Ca2+. Comparable pattern of responses were observed in the concentration-response curves to (S)-(−)-Bay K 8644, a L-type Ca2+ channel activator. Equilin was unable to block the transitory contraction produced by caffeine-induced Ca2+ release from intracellular stores. In conclusion, equilin blocks L-type Ca2+ channels less effectively than 17β-estradiol. Despite its lower effectiveness, equilin equally relaxes resistance mesenteric arteries by blocking Ca2+ entry on smooth muscle.

Original languageEnglish (US)
Pages (from-to)46-54
Number of pages9
JournalSteroids
DOIs
StatePublished - Jan 1 2019

Fingerprint

Equilin
Vasodilator Agents
Endothelium
Estradiol
Calcium
Mesenteric Arteries
Conjugated (USP) Estrogens
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Vasodilation
Blood Vessels
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Cyclic GMP-Dependent Protein Kinases
4-Aminopyridine
Tetraethylammonium
Glyburide
Guanylate Cyclase
Potassium Channels
NG-Nitroarginine Methyl Ester
Depolarization
Inbred SHR Rats

Keywords

  • 17β-Estradiol
  • Calcium channel
  • Equilin
  • Mesenteric arteries
  • Vasorelaxation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Filgueira, F. P., Lobato, N. S., Nascimento, D. L., Ceravolo, G. S., Giachini, F. R. C., Lima, V. V., ... Carvalho, M. H. C. (2019). Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, 46-54. https://doi.org/10.1016/j.steroids.2018.11.006

Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. / Filgueira, Fernando P.; Lobato, Núbia S.; Nascimento, Denise L.; Ceravolo, Graziela S.; Giachini, Fernanda R.C.; Lima, Victor V.; Dantas, Ana Paula; Fortes, Zuleica B.; Webb, R Clinton; Tostes, Rita C.; Carvalho, Maria Helena C.

In: Steroids, 01.01.2019, p. 46-54.

Research output: Contribution to journalArticle

Filgueira, FP, Lobato, NS, Nascimento, DL, Ceravolo, GS, Giachini, FRC, Lima, VV, Dantas, AP, Fortes, ZB, Webb, RC, Tostes, RC & Carvalho, MHC 2019, 'Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry', Steroids, pp. 46-54. https://doi.org/10.1016/j.steroids.2018.11.006
Filgueira, Fernando P. ; Lobato, Núbia S. ; Nascimento, Denise L. ; Ceravolo, Graziela S. ; Giachini, Fernanda R.C. ; Lima, Victor V. ; Dantas, Ana Paula ; Fortes, Zuleica B. ; Webb, R Clinton ; Tostes, Rita C. ; Carvalho, Maria Helena C. / Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. In: Steroids. 2019 ; pp. 46-54.
@article{d32005652e7a4381a28baecea25f5e50,
title = "Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry",
abstract = "Conjugated equine estrogens (CEE) have been widely used by women who seek to relieve symptoms of menopause. Despite evidence describing protective effects against risk factors for cardiovascular diseases by naturally occurring estrogens, little is known about the vascular effects of equilin, one of the main components of CEE and not physiologically present in women. In this regard, the present study aims to compare the vascular effects of equilin in an experimental model of hypertension with those induced by 17β-estradiol. Resistance mesenteric arteries from female spontaneously hypertensive rats (SHR) were used for recording isometric tension in a small vessel myograph. As effectively as 17β-estradiol, equilin evoked a concentration-dependent relaxation in mesenteric arteries from female SHRs contracted with KCl, U46619, PDBu or ET-1. Equilin-induced vasodilation does not involve classical estrogen receptor activation, since the estrogen receptor antagonist (ICI 182,780) failed to inhibit relaxation in U46619-precontracted mesenteric arteries. Vasorelaxation was not affected by either endothelium removal or by inhibiting the release or action of endothelium-derived factors. Incubation with L-NAME (NOS inhibitor), ODQ (guanylyl cyclase inhibitor) or KT5823 (inhibitor of protein kinase G) did not affect equilin-induced relaxation. Similarly, indomethacin (COX inhibitor) or blockage of potassium channels with tetraethylammonium, glibenclamide, 4-aminopyridine, or ouabain did not affect equilin-induced relaxation. Inhibitors of adenylyl cyclase SQ22536 or protein kinase A (KT5720) also had no effects on equilin-induced relaxation. While 17β-estradiol inhibited calcium (Ca2+) -induced contractions in high-K+ depolarization medium in a concentration-dependent manner, equilin induced a slight rightward-shift in the contractile responses to Ca2+. Comparable pattern of responses were observed in the concentration-response curves to (S)-(−)-Bay K 8644, a L-type Ca2+ channel activator. Equilin was unable to block the transitory contraction produced by caffeine-induced Ca2+ release from intracellular stores. In conclusion, equilin blocks L-type Ca2+ channels less effectively than 17β-estradiol. Despite its lower effectiveness, equilin equally relaxes resistance mesenteric arteries by blocking Ca2+ entry on smooth muscle.",
keywords = "17β-Estradiol, Calcium channel, Equilin, Mesenteric arteries, Vasorelaxation",
author = "Filgueira, {Fernando P.} and Lobato, {N{\'u}bia S.} and Nascimento, {Denise L.} and Ceravolo, {Graziela S.} and Giachini, {Fernanda R.C.} and Lima, {Victor V.} and Dantas, {Ana Paula} and Fortes, {Zuleica B.} and Webb, {R Clinton} and Tostes, {Rita C.} and Carvalho, {Maria Helena C.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.steroids.2018.11.006",
language = "English (US)",
pages = "46--54",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry

AU - Filgueira, Fernando P.

AU - Lobato, Núbia S.

AU - Nascimento, Denise L.

AU - Ceravolo, Graziela S.

AU - Giachini, Fernanda R.C.

AU - Lima, Victor V.

AU - Dantas, Ana Paula

AU - Fortes, Zuleica B.

AU - Webb, R Clinton

AU - Tostes, Rita C.

AU - Carvalho, Maria Helena C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Conjugated equine estrogens (CEE) have been widely used by women who seek to relieve symptoms of menopause. Despite evidence describing protective effects against risk factors for cardiovascular diseases by naturally occurring estrogens, little is known about the vascular effects of equilin, one of the main components of CEE and not physiologically present in women. In this regard, the present study aims to compare the vascular effects of equilin in an experimental model of hypertension with those induced by 17β-estradiol. Resistance mesenteric arteries from female spontaneously hypertensive rats (SHR) were used for recording isometric tension in a small vessel myograph. As effectively as 17β-estradiol, equilin evoked a concentration-dependent relaxation in mesenteric arteries from female SHRs contracted with KCl, U46619, PDBu or ET-1. Equilin-induced vasodilation does not involve classical estrogen receptor activation, since the estrogen receptor antagonist (ICI 182,780) failed to inhibit relaxation in U46619-precontracted mesenteric arteries. Vasorelaxation was not affected by either endothelium removal or by inhibiting the release or action of endothelium-derived factors. Incubation with L-NAME (NOS inhibitor), ODQ (guanylyl cyclase inhibitor) or KT5823 (inhibitor of protein kinase G) did not affect equilin-induced relaxation. Similarly, indomethacin (COX inhibitor) or blockage of potassium channels with tetraethylammonium, glibenclamide, 4-aminopyridine, or ouabain did not affect equilin-induced relaxation. Inhibitors of adenylyl cyclase SQ22536 or protein kinase A (KT5720) also had no effects on equilin-induced relaxation. While 17β-estradiol inhibited calcium (Ca2+) -induced contractions in high-K+ depolarization medium in a concentration-dependent manner, equilin induced a slight rightward-shift in the contractile responses to Ca2+. Comparable pattern of responses were observed in the concentration-response curves to (S)-(−)-Bay K 8644, a L-type Ca2+ channel activator. Equilin was unable to block the transitory contraction produced by caffeine-induced Ca2+ release from intracellular stores. In conclusion, equilin blocks L-type Ca2+ channels less effectively than 17β-estradiol. Despite its lower effectiveness, equilin equally relaxes resistance mesenteric arteries by blocking Ca2+ entry on smooth muscle.

AB - Conjugated equine estrogens (CEE) have been widely used by women who seek to relieve symptoms of menopause. Despite evidence describing protective effects against risk factors for cardiovascular diseases by naturally occurring estrogens, little is known about the vascular effects of equilin, one of the main components of CEE and not physiologically present in women. In this regard, the present study aims to compare the vascular effects of equilin in an experimental model of hypertension with those induced by 17β-estradiol. Resistance mesenteric arteries from female spontaneously hypertensive rats (SHR) were used for recording isometric tension in a small vessel myograph. As effectively as 17β-estradiol, equilin evoked a concentration-dependent relaxation in mesenteric arteries from female SHRs contracted with KCl, U46619, PDBu or ET-1. Equilin-induced vasodilation does not involve classical estrogen receptor activation, since the estrogen receptor antagonist (ICI 182,780) failed to inhibit relaxation in U46619-precontracted mesenteric arteries. Vasorelaxation was not affected by either endothelium removal or by inhibiting the release or action of endothelium-derived factors. Incubation with L-NAME (NOS inhibitor), ODQ (guanylyl cyclase inhibitor) or KT5823 (inhibitor of protein kinase G) did not affect equilin-induced relaxation. Similarly, indomethacin (COX inhibitor) or blockage of potassium channels with tetraethylammonium, glibenclamide, 4-aminopyridine, or ouabain did not affect equilin-induced relaxation. Inhibitors of adenylyl cyclase SQ22536 or protein kinase A (KT5720) also had no effects on equilin-induced relaxation. While 17β-estradiol inhibited calcium (Ca2+) -induced contractions in high-K+ depolarization medium in a concentration-dependent manner, equilin induced a slight rightward-shift in the contractile responses to Ca2+. Comparable pattern of responses were observed in the concentration-response curves to (S)-(−)-Bay K 8644, a L-type Ca2+ channel activator. Equilin was unable to block the transitory contraction produced by caffeine-induced Ca2+ release from intracellular stores. In conclusion, equilin blocks L-type Ca2+ channels less effectively than 17β-estradiol. Despite its lower effectiveness, equilin equally relaxes resistance mesenteric arteries by blocking Ca2+ entry on smooth muscle.

KW - 17β-Estradiol

KW - Calcium channel

KW - Equilin

KW - Mesenteric arteries

KW - Vasorelaxation

UR - http://www.scopus.com/inward/record.url?scp=85057262356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057262356&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2018.11.006

DO - 10.1016/j.steroids.2018.11.006

M3 - Article

SP - 46

EP - 54

JO - Steroids

JF - Steroids

SN - 0039-128X

ER -